//
A Randomized Controlled Trial to Evaluate the Safety and Efficacy of Cardiac Contractility Modulation
Longitudinal Change in Galectin-3 and Incident Cardiovascular Outcomes
The Management of Atrial Fibrillation in Heart Failure: An Expert Panel Consensus
Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction
Positive recommendation for angiotensin receptor/neprilysin inhibitor: First medication approval for heart failure without "reduced ejection fraction"
Dapagliflozin for treating chronic heart failure with reduced ejection fraction
Cardiac Implantable Electronic Devices in Patients With Left Ventricular Assist Systems
Effect of Empagliflozin on Cardiovascular and Renal Outcomes in Patients With Heart Failure by Baseline Diabetes Status - Results from the EMPEROR-Reduced Trial